Proteasome inhibitor MLN9708, Purity ≥98%

Cat. No.: X24-07-ZQ701

Proteasome inhibitor MLN9708, Purity ≥98%

Synonym: 1201902-80-8; Proteasome inhibitor; MLN-9708

  • MDL: MFCD18251437
  • CAS Number: 1201902-80-8
  • Compound CID: 49867936
Product Size
5 mg; 10 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
MLN9708, soluble in DMSO and insoluble in ethanol and water, interferes with the proteasome’s ability to degrade proteins, thereby disrupting cellular processes in cancer cells, particularly multiple myeloma. It targets 20S proteasome and 20S proteasome.
Molecular Weight
517.1
Molecular Formula
C20H23BCl2N2O9
Targets
20S proteasome: 0.93 nM (Ki); 20S proteasome: 3.4 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 85 mg/mL (164.36 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Applications
MLN9708 is applied in studies focused on proteasome inhibition, which is a strategy used in cancer therapy, particularly for multiple myeloma.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0